UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

The compact three-phase Smart Sensor Current ESS 076 with IO-Link is able to measure all three phases in a single device. This simplifies continuous monitoring and provides the basis for targeted ...

KKR and Pinewood-owner Aermont join race to bed down with staycation provider Park Holidays The global investment giant KKR and the owner of Pinewood Studios have joined the race to snap up Park ...